Budget Amount *help |
¥25,740,000 (Direct Cost: ¥19,800,000、Indirect Cost: ¥5,940,000)
Fiscal Year 2012: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2011: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2010: ¥15,210,000 (Direct Cost: ¥11,700,000、Indirect Cost: ¥3,510,000)
|
Research Abstract |
We attempted to develop a modality by which angiogenic directions are rectified in ischemic retinopathy. During development, binding of neuron-derived Sema3E to endothelial PlexinD1 activated RhoJ, thereby retracting disoriented angiogenesis. In a mouse model of ischemic retinopathy, intravitreal injections of Sema3E protein selectively prevented disoriented angiogenesis without affecting retinal vascular regeneration. Theses results present a new paradigm of vascular regeneration therapy that guides new blood vessels toward the ischemic retinas.
|